Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Devensoft

AUGUST 22, 2023

Similarly, when companies from different geographic regions aim to collaborate, freelance modeling can cater to the complexities of cross-cultural integration. Consider a merger between a pharmaceutical company and a biotech startup. Conventional integration plans might have been rigid, focusing solely on aligning technical systems.

M&A 52

M&A Business Mergers and Acquisitions Collaboration 52

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Collaborate or buy?’ Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 2019 was a banner year for billion-dollar life sciences M&A transactions.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

Software Equity Group

AUGUST 20, 2024

The software provides features for data sharing, email notifications, permission management, reminders, web and mobile interfaces, collaboration, and dashboards. Splunk’s software enables business intelligence, predictive analytics, monitoring, and management of applications, IT operations, and security.

Investment 52

Investment Management Acquisitions Business 52

Software Equity Group

JANUARY 22, 2024

A shift to patient-centered care A growing body of research and consumer demand are pushing healthcare organizations to adopt a more personalized, collaborative, comprehensive approach to caring for patients’ whole-health needs. It enables interoperability between clinical, administrative and financial systems, and makes data more secure.

Healthcare 52

Healthcare M&A Valuation Medical 52

Software Equity Group

JANUARY 22, 2024

A shift to patient-centered care A growing body of research and consumer demand are pushing healthcare organizations to adopt a more personalized, collaborative, comprehensive approach to caring for patients’ whole-health needs. It enables interoperability between clinical, administrative and financial systems, and makes data more secure.

Healthcare 52

Healthcare M&A Valuation Medical 52